Featured Research

from universities, journals, and other organizations

Infection Rates Low With New Cataract Surgery Techniques

Date:
March 12, 2009
Source:
American Academy of Ophthalmology
Summary:
It is well known that people with light skin and numerous moles and freckles -- which develop when skin is over-exposed to UV light -- are at higher risk for skin cancer (cutaneous melanoma). But the evidence was less clear on whether moles and freckles also indicate a higher risk of uveal melanoma, cancer of the eye's iris, ciliary body, or choroid.

A large study by Canadian researchers has found that endophthalmitis, a serious infection of the inner eye, continues to be rare following cataract surgery.

Because surgical techniques and patient selection criteria have evolved rapidly in the past several years, the researchers wanted to learn whether infection risks were changing as a result. The largest previous study, completed in 2001 using records of half-million United States Medicare cataract patients, had documented very low infection rates.

Chaim M. Bell, MD, PhD, and Wendy Hatch OD, MSc, University of Toronto, Canada, and their colleagues reviewed records for more than 440,000 consecutive cataract surgeries performed in surgical facilities in Ontario, Canada, between April 2002 and March 2006. Facilities where more than 50 cataract surgeries were performed annually were included. To estimate infection rates, the study tracked post-operative procedures to treat suspected infections that occurred within 14 days of cataract surgery.

The overall rate of suspected acute endophthalmitis was very low: 1.4 per 1,000 surgeries. Patients who required procedures to correct ruptures of their lens capsule, the structure that contains the eye's lens, during their cataract surgery were about 10 times more likely to develop suspected infection, but fewer than 1 in 200 sustained such a rupture.

The highest rate of suspected endophthalmitis occurred in patients over age 85 (2.18 per 1,000). Men were at somewhat higher risk than women (1.7 vs. 1.19 per 1,000). No differences in rates were found between patients living in rural vs. non-rural settings, nor were differences noted among socioeconomic groups.

No upward or downward trend in suspected endophthalmitis related to cataract surgery was evident during the study period.

The research was published in the March issue of Ophthalmology, the journal of the American Academy of Ophthalmology.


Story Source:

The above story is based on materials provided by American Academy of Ophthalmology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Ophthalmology. "Infection Rates Low With New Cataract Surgery Techniques." ScienceDaily. ScienceDaily, 12 March 2009. <www.sciencedaily.com/releases/2009/03/090302214652.htm>.
American Academy of Ophthalmology. (2009, March 12). Infection Rates Low With New Cataract Surgery Techniques. ScienceDaily. Retrieved July 21, 2014 from www.sciencedaily.com/releases/2009/03/090302214652.htm
American Academy of Ophthalmology. "Infection Rates Low With New Cataract Surgery Techniques." ScienceDaily. www.sciencedaily.com/releases/2009/03/090302214652.htm (accessed July 21, 2014).

Share This




More Health & Medicine News

Monday, July 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins